Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BY 4.0Angiogenesis

VEGFR2-dependent VEGFR3 expression leads to CXCL1/2 and CXCR2 induction in the development of retinal neovascularization

  1. 1Department of Physiology, University of Tennessee Health Science Center, 71 S Manassas Street, Memphis, TN 38163 USA

Abstract

Elevated levels of IL-8 have been detected in the vitreous samples of patients with diabetic retinopathy. However, its role in retinal neovascularization remains unknown. We hypothesized that IL-8 and its murine orthologues, CXCL1/2, are key mediators of oxygen-induced retinopathy (OIR)-driven retinal angiogenesis. To this end, we found that VEGFA stimulates CXCL1/2 and their receptor CXCR2 expression in mouse retinal microvascular endothelial cells (MRMVECs) in a time-dependent manner. Recombinant CXCL1/2 induced MRMVEC migration, proliferation, sprouting, and tube formation alone and in combination. Neutralizing CXCL1/2 or CXCR2 antibodies (Abs) attenuated the angiogenic effects of CXCL1/2 as well as VEGFA. In line with these observations in mice, VEGFA induced IL-8 and its receptor CXCR2 expression in human retinal microvascular endothelial cells (HRMVECs), and neutralizing IL-8 or CXCR2 Abs suppressed their angiogenic effects. Furthermore, OIR induced CXCL1/2 and CXCR2 expression in the mouse retina in vivo, and blockade of their function using their neutralizing Abs reduced retinal neovascularization. Mechanistically, depletion of ATF6 or GRP78 levels abrogated VEGFA-induced CXCL1/2 and CXCR2 expression in MRMVECs and IL-8 and CXCR2 expression in HRMVECs in vitro and OIR-induced CXCL1/2 and CXCR2 expression in vivo in mice. Furthermore, silencing VEGFR2 or VEGFR3 levels inhibited VEGFA/OIR-induced ATF6-GRP78 activation and their downstream CXCL1/2, IL-8 and CXCR2 expression both in vitro and in vivo. Together, these findings identify IL-8 as potential therapeutic target for treating retinal neovascular diseases.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s10456-026-10104-1.

Related

  1. Mapping Retinal Gene Expression to Cell Classes: Insights into Retinal Circadian Rhythms.
    Julia Buckland, Michael J Gilhooley, Mark W Hankins +2
    Clocks & sleepPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  2. Correlating relative light sensitivity to retinal visual gene expression patterns in three African cichlid fish species
    Gerrit Potkamp, Elena Zhemchuzhnikova, Felicity van Geresteijn +6
    Biology OpenPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  3. PERK/ATF3-dependent induction of GDE4 modulates intracellular lysophospholipid-PPARα/γ signaling
    K. Kitakaze, R. Misumi, S. Nagai +12
    bioRxivPreprintCC BYFull textMolecular biology & gene regulationbioRxiv
  4. SR-A1 cooperates with TLR4-NF-κB signaling to drive macrophage TGF-β1 expression and Treg induction during schistosome infection
    Junyao Shen, Ziling Wang, Chuanhong Huang +14
    PLOS PathogensPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCell biologyPLOS
  5. The African swine fever virus I73R protein is a multifunctional Zα domain that mediates both Z-binding-dependent and -independent biological functions through induction of phase separation
    Sébastien Pirotte, Yingnan Liu, Laurie Conti +12
    Nucleic Acids ResearchPeer-reviewedCC BY-NCFull textMolecular biology & gene regulationCrossrefEurope PMCPMC
BibTeX
@article{yadavalli2026vegfr2dependent,
  title = {{VEGFR2-dependent VEGFR3 expression leads to CXCL1/2 and CXCR2 induction in the development of retinal neovascularization}},
  author = {Chandra Sekhar Yadavalli and Raj Kumar and Suresh Govatati and Gadiparthi N. Rao},
  journal = {Angiogenesis},
  year = {2026},
  month = oct,
  doi = {10.1007/s10456-026-10104-1},
  url = {https://doi.org/10.1007/s10456-026-10104-1},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - VEGFR2-dependent VEGFR3 expression leads to CXCL1/2 and CXCR2 induction in the development of retinal neovascularization
AU  - Chandra Sekhar Yadavalli
AU  - Raj Kumar
AU  - Suresh Govatati
AU  - Gadiparthi N. Rao
PY  - 2026
DA  - 2026/10/25
JO  - Angiogenesis
DO  - 10.1007/s10456-026-10104-1
UR  - https://doi.org/10.1007/s10456-026-10104-1
AB  - Elevated levels of IL-8 have been detected in the vitreous samples of patients with diabetic retinopathy. However, its role in retinal neovascularization remains unknown. We hypothesized that IL-8 and its murine orthologues, CXCL1/2, are key mediators of oxygen-induced retinopathy (OIR)-driven retinal angiogenesis. To this end, we found that VEGFA stimulates CXCL1/2 and their receptor CXCR2 expression in mouse retinal microvascular endothelial cells (MRMVECs) in a time-dependent manner. Recombinant CXCL1/2 induced MRMVEC migration, proliferation, sprouting, and tube formation alone and in combination. Neutralizing CXCL1/2 or CXCR2 antibodies (Abs) attenuated the angiogenic effects of CXCL1/2 as well as VEGFA. In line with these observations in mice, VEGFA induced IL-8 and its receptor CXCR2 expression in human retinal microvascular endothelial cells (HRMVECs), and neutralizing IL-8 or CXCR2 Abs suppressed their angiogenic effects. Furthermore, OIR induced CXCL1/2 and CXCR2 expression in the mouse retina in vivo, and blockade of their function using their neutralizing Abs reduced retinal neovascularization. Mechanistically, depletion of ATF6 or GRP78 levels abrogated VEGFA-induced CXCL1/2 and CXCR2 expression in MRMVECs and IL-8 and CXCR2 expression in HRMVECs in vitro and OIR-induced CXCL1/2 and CXCR2 expression in vivo in mice. Furthermore, silencing VEGFR2 or VEGFR3 levels inhibited VEGFA/OIR-induced ATF6-GRP78 activation and their downstream CXCL1/2, IL-8 and CXCR2 expression both in vitro and in vivo. Together, these findings identify IL-8 as potential therapeutic target for treating retinal neovascular diseases.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s10456-026-10104-1.
SN  - 0969-6970
SN  - 1573-7209
ER  -